🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 4 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/08/2020 44,83 45,73 43,76 44,97 +0,97% 4,39% 627.400
18/08/2020 45,77 46,40 43,35 44,54 -2,54% 6,67% 1.139.400
17/08/2020 42,15 46,54 42,15 45,70 +8,78% 10,42% 1.397.700
14/08/2020 42,61 42,85 41,40 42,01 -1,64% 3,40% 549.600
13/08/2020 42,45 42,91 40,81 42,71 -0,23% 4,95% 850.900
12/08/2020 40,63 43,02 40,63 42,81 +5,50% 5,87% 922.900
11/08/2020 41,17 42,18 40,21 40,58 +0,52% 4,79% 1.006.100
10/08/2020 40,07 40,78 39,61 40,37 +0,35% 2,92% 708.300
07/08/2020 41,50 42,00 39,56 40,23 -1,93% 5,88% 921.700
06/08/2020 43,09 44,39 40,01 41,02 -5,83% 10,16% 1.297.600
05/08/2020 44,72 44,72 42,67 43,56 -1,27% 4,58% 1.206.100
04/08/2020 44,00 44,63 43,29 44,12 -0,59% 3,05% 498.800
03/08/2020 43,41 44,49 42,88 44,38 +3,04% 3,71% 625.100
31/07/2020 45,55 45,80 42,62 43,07 -5,24% 6,98% 972.500
30/07/2020 43,67 46,00 43,27 45,45 +2,60% 6,25% 561.000
29/07/2020 45,77 46,30 44,00 44,30 -2,66% 5,03% 730.900
28/07/2020 48,25 48,49 45,47 45,51 -5,85% 6,26% 805.100
27/07/2020 46,49 48,44 46,00 48,34 +4,61% 5,25% 791.700
24/07/2020 45,72 46,82 45,04 46,21 -0,96% 3,89% 797.900
23/07/2020 48,80 49,40 46,32 46,66 -3,99% 6,31% 844.100
22/07/2020 48,75 49,66 47,36 48,60 -0,31% 4,71% 793.100
21/07/2020 51,75 52,00 48,42 48,75 -4,92% 6,92% 1.094.100
20/07/2020 49,13 51,54 48,76 51,27 +4,59% 5,66% 1.174.800
17/07/2020 48,88 49,99 48,72 49,02 +0,00% 2,60% 923.900
16/07/2020 47,98 49,31 47,44 49,02 +1,74% 3,90% 772.000
15/07/2020 48,09 48,75 47,18 48,18 +1,77% 3,26% 894.900
14/07/2020 46,11 47,39 45,20 47,34 +2,62% 4,75% 1.460.300
13/07/2020 45,00 48,97 44,70 46,13 +3,64% 9,49% 1.829.100
10/07/2020 45,28 45,85 44,42 44,51 -1,31% 3,16% 728.000
09/07/2020 45,30 46,27 44,34 45,10 -0,33% 4,27% 1.034.800